Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Theravance Biopharma, Inc. (TBPH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
10.49-0.11 (-1.04%)
At close: 04:00PM EST
10.49 0.00 (0.00%)
After hours: 04:10PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close10.60
Open10.53
Bid10.00 x 900
Ask11.77 x 1000
Day's Range10.43 - 10.66
52 Week Range7.53 - 13.17
Volume767,730
Avg. Volume776,268
Market Cap706.668M
Beta (5Y Monthly)0.52
PE Ratio (TTM)N/A
EPS (TTM)-2.02
Earnings DateFeb 21, 2023 - Feb 27, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.90
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for TBPH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Theravance Biopharma, Inc.
    ENTA: Lowering target price to $47.00ENANTA PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $47.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more
  • PR Newswire

    Theravance Biopharma, Inc. Announces Final Results of Tender Offer

    Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced the final results of its Dutch auction tender offer (the "Offer") to purchase up to $95 million of its ordinary shares, par value $0.00001 per share (the "Shares"), which expired at midnight, New York City time, at the end of the day on November 17, 2022.

  • PR Newswire

    Theravance Biopharma, Inc. Announces Preliminary Results of Tender Offer

    Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced the preliminary results of its Dutch auction tender offer (the "Offer") to purchase up to $95 million of its ordinary shares, par value $0.00001 per share (the "Shares"), which expired at midnight, New York City time, at the end of the day on November 17, 2022.

  • Simply Wall St.

    We Might See A Profit From Theravance Biopharma, Inc. (NASDAQ:TBPH) Soon

    Theravance Biopharma, Inc. ( NASDAQ:TBPH ) is possibly approaching a major achievement in its business, so we would...

Advertisement
Advertisement